
News|Articles|November 1, 2012
Dimethyl fumarate: A fumaric acid ester under investigation for treatment of relapsing-remitting multiple sclerosis
Dimethyl fumarate is an investigational drug being studied for the treatment of relapsing-remitting multiple sclerosis (RRMS).
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New cholesterol guideline expands treatment eligibility to 55% of U.S. adults
2
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1
3
Type 2 diabetes linked to more severe menopause symptoms, study finds
4
500,000 Medicaid beneficiaries with diabetes to lose coverage by 2034
5




















